Ftse Mib
33.285,03
0,17%
DAX
19.146,17
0,76%
S&P 500
5.952,23
0,59%
NASDAQ
19.011,95
0,24%
Bitcoin
98.922,63
4,84%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Esperion Therapeutics Inc (ESPR) Esperion Therapeutics Inc (ESPR) Notizie

Esperion Therapeutics Inc

ESPR
2,475
0,06 (2,48%)
Ultimo aggiornamento: 20:01:14
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
21/11/202414:00GLOBEEsperion to Participate in Upcoming Piper Sandler 36th..
20/11/202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/11/202422:07EDGAR2Form 144 - Report of proposed sale of securities
18/11/202416:30GLOBEEsperion Highlights New Exploratory Data from CLEAR Outcomes..
14/11/202414:42EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
08/11/202422:15GLOBEEsperion Announces Inducement Grants Under NASDAQ Listing..
07/11/202422:22EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202413:22EDGAR2Form 8-K - Current report
07/11/202412:19IHMARKETNEWSU.S. Futures Rise as Investors Await Fed Rate Decision; Oil..
07/11/202412:00GLOBEEsperion Reports Third Quarter 2024 Financial Results and..
04/11/202414:00GLOBEEsperion to Participate in Upcoming Jefferies London..
31/10/202413:00GLOBEEsperion Announces a Featured Presentation in the Late..
24/10/202414:00GLOBEEsperion to Report Third Quarter 2024 Financial Results on..
23/10/202400:06EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
18/10/202422:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/10/202421:25EDGAR2Form 144 - Report of proposed sale of securities
02/10/202414:00GLOBEEsperion EU Partner Reports Final Real-World Results from..
25/9/202422:30GLOBEEsperion Announces Inducement Grant Under NASDAQ Listing..
18/9/202422:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/9/202422:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/9/202422:02EDGAR2Form 144 - Report of proposed sale of securities
17/9/202421:28EDGAR2Form 144 - Report of proposed sale of securities
17/9/202421:20EDGAR2Form 144 - Report of proposed sale of securities
05/9/202414:00GLOBEEsperion to Participate in Upcoming 2024 Cantor Global..
03/9/202414:00GLOBEEsperion Secures Additional Commercial and Medicare..
26/8/202414:00GLOBEEsperion to Participate in Upcoming H.C. Wainwright 26th..
20/8/202422:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/8/202421:50EDGAR2Form 144 - Report of proposed sale of securities
12/8/202422:33EDGAR2Form S-8 - Securities to be offered to employees in employee..
12/8/202422:08EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
12/8/202413:21EDGAR2Form 8-K - Current report
12/8/202412:00GLOBEEsperion Reports Second Quarter 2024 Financial Results and..
12/8/202411:47IHMARKETNEWSU.S. Futures Steady as Markets Await Key Inflation Data, Oil..
07/8/202422:30GLOBEEsperion Announces Inducement Grants Under NASDAQ Listing..
05/8/202422:34EDGAR2Form 8-K - Current report
25/7/202414:00GLOBEEsperion to Report Second Quarter 2024 Financial Results on..
24/7/202414:00GLOBEEsperion to Participate in Upcoming BTIG Biotech Conference
19/7/202414:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/7/202414:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/7/202421:22EDGAR2Form 144 - Report of proposed sale of securities
17/7/202421:11EDGAR2Form 144 - Report of proposed sale of securities
16/7/202414:00GLOBENew Digital First Marketing Campaign from Esperion Alerts..
28/6/202413:00GLOBEEsperion Announces Monetization of European Royalties and..
18/6/202421:19EDGAR2Form 144 - Report of proposed sale of securities
18/6/202421:09EDGAR2Form 144 - Report of proposed sale of securities
28/5/202422:16EDGAR2Form 8-K - Current report
24/5/202422:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/5/202422:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/5/202422:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/5/202415:00GLOBEEsperion to Participate in Upcoming June Investor..
Apertura: 2,39 Min: 2,35 Max: 2,51
Chiusura: 2,415

La tua Cronologia

NASDAQ
ESPR
Esperion Therapeutics
BIT
1COP
ConocoPhillips
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network